Side-by-side comparison of AI visibility scores, market position, and capabilities
NY digital health platform with owned pharmacy at $350M revenue in men's health, women's health, and GLP-1 weight management; $876M raised competing with Hims & Hers for DTC telehealth prescription delivery.
Ro is a New York-based digital health platform — backed with $876 million raised from General Catalyst, SignalFire, L Catterton, and others at a peak $7 billion valuation — providing telemedicine consultations, prescription management, and pharmacy-grade medication delivery for men's health (erectile dysfunction, hair loss under the Roman brand), women's health (fertility, menopause under the Rory brand), primary care (Ro Primary Care), and weight management (body program with GLP-1 medications). Founded in 2017 by Zachariah Reitano, Rob Schutz, and Saman Rahmanian, Ro generated approximately $350 million in revenue in 2024, serving over 2 million patients who have completed consultations through its platforms.
UnitedHealth Group (NYSE: UNH) health services at $226B revenue combining Optum Health clinics, Optum Rx PBM for 65M+, and Change Healthcare analytics; largest US health services company competing with CVS/Caremark.
Optum is the health services subsidiary of UnitedHealth Group (NYSE: UNH) — one of the world's largest companies with $400 billion in annual revenue — operating Optum Health (care delivery: primary care clinics, urgent care, surgical centers), Optum Rx (pharmacy benefit management: managing drug benefits for 65+ million people), and Optum Insight (health data analytics, technology, and consulting for health plans, providers, and government). With $226 billion in annual revenue in its own right (making Optum larger than most standalone health companies), Optum generates approximately 50% of UnitedHealth Group's total revenue and is the largest health services company in the world.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.